Financhill
Back

Autolus Therapeutics Plc 10K Form

Sell
42

AUTL
Autolus Therapeutics Plc

Last Price:
$1.58
Seasonality Move:
0.92%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AUTL News And Ratings

See the #1 stock for the next 7 days that we like better than AUTL

AUTL Financial Statistics

Sales & Book Value

Annual Sales: $10.1M
Cash Flow: $-79.9M
Price / Cash Flow: 0
Annual Sales: $0.75
Price / Book: 1.98

Profitability

EPS (TTM): -0.84410
Net Income (TTM): $-224.6M
Gross Margin: $-9M
Return on Equity: -59.51%
Return on Assets: -30.04%

Autolus Therapeutics Plc Earnings Forecast

Key Autolus Therapeutics Plc Financial Ratios

  • The Gross Profit Margin over the past 4 years for AUTL is -88.76%.
  • The Selling, General & Administrative Expenses for AUTL have been equal to 998.87% of Gross Profit Margin.
  • The Research & Development expenses have been 1,173.28% of Revenue.
  • The Net Earning history of AUTL is -2,180.45% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 6 years.

Autolus Therapeutics Plc Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: AUTL
CUSIP: 05280R
Website: autolus.com

Debt

Debt-to-Equity Ratio: 1.23
Current Ratio: 6.15
Quick Ratio: 4.83

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

AUTL Technical Analysis vs Fundamental Analysis

Sell
42
Autolus Therapeutics Plc (AUTL) is a Sell

Is Autolus Therapeutics Plc a Buy or a Sell?